Inoviv is excited to announce the official launch of MasterKey™, a platform enabling rapid selection and development of targeted proteomics assays. Researchers can choose from a comprehensive database of thousands of curated proteins, with new additions updated monthly. Researchers and drug developers can harness MasterKey™ to select over 50+ proteins for the development of quantitative multiplex assays, streamlining their research processes with exceptional precision and reliability. Discover how MasterKey™ can revolutionize your research. Read the full press release here - https://lnkd.in/gPNZuGQu #biopharma #biomarkerdiscovery #biopharmaceuticals #massspec #massspectrometry #precisionmedicine #clinicaltrials #proteomics #drugdevelopment
Inoviv
Biotechnology
London, England 3,105 followers
Accelerating the Development of New Medicines with Targeted Proteomics
About us
Inoviv uses a novel technology platform based on targeted proteomics to support pharmaceutical companies with biomarker test development.
- Website
-
http://www.inoviv.com
External link for Inoviv
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- London, England
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Proteomics, Biomarker Discovery, Translational Biomarkers, Mass Spectrometry, Targeted Proteomics, Discovery Proteomics, Biomarkers, Precision Medicine, Proteomic Analysis, Proteome Profiling , Quantitative Proteomics, Liquid Chromatography Mass-Spectrometry (LC-MS), Post-Translational Modifications (PTMs), Quantitative Biomarkers, Clinical Proteomics, Immuno-Precipitation Mass Spectrometry (IP-MS), Proteins, LC-MS Proteomics, Proteomics Services, and Protein Identification
Locations
-
Primary
4 Winsley St
Mappin House
London, England W1W 8HF, GB
-
100 Cambridge Street
Boston, Massachusetts 02114, US
Employees at Inoviv
-
Rob Kniaz
Co-founder - Hoxton Ventures & H Tree Capital - Tech:Bio & Deep Tech
-
ronan o'cualain
I am a clinical analyst specialised in Proteomics. I am happy when collaborating as part of a team in the development, optimisation and validation of…
-
Lucy-Rose Walker
Enabling Humans | Startup Support specialising in people and culture | Facilitator | An outsider working inside your business!
-
Abhinav K.
15 yrs in mass spectrometry applications such as: Discovery & Targeted Proteomics, Biologics Characterization, Clinical Mass Spectrometry…
Updates
-
Take a closer look with MasterKey™, Inoviv’s newly launched customizable platform. MasterKey™ lets users custom-select proteins directly in-app, enabling the precise and efficient design of targeted mass spectrometry assays. Watch the video to see how MasterKey™ is transforming the development of quantitative multiplexed biomarker assays. Discover more about MasterKey™ and its capabilities - <<<https://lnkd.in/eeqQJKnW>>> #biopharma #biomarkerdiscovery #biopharmaceuticals #massspec #massspectrometry #precisionmedicine #clinicaltrials #proteomics #drugdevelopment
Custom Multiplexed Targeted Biomarker Assays | MasterKey™
-
“10/10 applicant experience”. Thank you Amber Penrose for the entertaining and encouraging review of our careers page! Also a big shout out to Open Org for helping us embody what transparency means and the values that make us unique. Check out our open roles or send us an open application. Open Roles: https://lnkd.in/eEm6KSCH Open application: https://lnkd.in/eF9eYwY2
Stop right now. Thank you very much. Another biotech careers page with a human touch!? 😲 🎶 Introducing Inoviv (Proteomics start-up in London) and their bloody brilliant candidate journey. 👏 👏 👏 Check out their Notion for an example of a 10/10 applicant experience in the 'Omics space. Link in the comments! #spiceupyourseq #spiceupyourlife
-
Inoviv reposted this
People Leader | Scaling SMEs | Tech-for-good | Employee experience | Wellbeing | Organisational effectiveness | Data driven | Successful PE exit
So proud to introduce MasterKey to the world! This platform showcases the brilliant work of our talented team, and allows researchers to customise protein assays for better therapeutic outcomes. I’m excited to see how MasterKey can support our mission to transform drug development and healthcare globally.
Inoviv is excited to announce the official launch of MasterKey™, a platform enabling rapid selection and development of targeted proteomics assays. Researchers can choose from a comprehensive database of thousands of curated proteins, with new additions updated monthly. Researchers and drug developers can harness MasterKey™ to select over 50+ proteins for the development of quantitative multiplex assays, streamlining their research processes with exceptional precision and reliability. Discover how MasterKey™ can revolutionize your research. Read the full press release here - https://lnkd.in/gPNZuGQu #biopharma #biomarkerdiscovery #biopharmaceuticals #massspec #massspectrometry #precisionmedicine #clinicaltrials #proteomics #drugdevelopment
Press Release | Inoviv Launches MasterKey™
https://www.inoviv.com
-
Inoviv reposted this
Proud to share that MasterKey is now live! This platform exemplifies our commitment to technological excellence, enabling researchers to create custom protein assays with unparalleled precision. Bringing this vision to life has been a remarkable experience. Made possible by the hard work and innovation of our team, MasterKey will drive significant advancements in therapeutic and clinical research. This tool is integral to our mission of transforming drug development. Congratulations to everyone at Inoviv for this outstanding achievement. https://lnkd.in/eNxcvPdR
Inoviv Launches MasterKey™, A Customizable Platform for Multiplexed Targeted Protein Assays, Leveraging a Pre-Characterized Database of Thousands of Proteins
prnewswire.com
-
Inoviv reposted this
Chief Scientific Officer & Co-Founder | Accelerating the Development of New Medicines with Targeted Proteomics Biomarkers
We are proud to unveil MasterKey, a platform that represents the culmination of years of rigorous research and collaboration. Designed to advance scientific discovery with precise protein assays, our team's relentless effort and passion have made this possible. I am excited to see the impact it will have on pre-clinical and clinical research. https://lnkd.in/eB4R275h #proteomics #LCMS #clinicaltrials
Inoviv Launches MasterKey™, A Customizable Platform for Multiplexed Targeted Protein Assays, Leveraging a Pre-Characterized Database of Thousands of Proteins
prnewswire.com
-
Inoviv reposted this
Rocking and rolling! Excited for Inoviv's next evolution in supporting the drug development landscape. We know how difficult it can be, and how long it takes, to ID and select new protein biomarkers. We're leveraging our extensive knowledge and experience in characterization to allow researchers to 'choose their own adventure' and create multi-plex targeted assays directly from our curated database.
Inoviv is excited to announce the official launch of MasterKey™, a platform enabling rapid selection and development of targeted proteomics assays. Researchers can choose from a comprehensive database of thousands of curated proteins, with new additions updated monthly. Researchers and drug developers can harness MasterKey™ to select over 50+ proteins for the development of quantitative multiplex assays, streamlining their research processes with exceptional precision and reliability. Discover how MasterKey™ can revolutionize your research. Read the full press release here - https://lnkd.in/gPNZuGQu #biopharma #biomarkerdiscovery #biopharmaceuticals #massspec #massspectrometry #precisionmedicine #clinicaltrials #proteomics #drugdevelopment
Press Release | Inoviv Launches MasterKey™
https://www.inoviv.com
-
Inoviv reposted this
Say hi to MasterKey! Resulting from years of development, this platform offers customisable mass spectrometry-based protein assays with exceptional performance, ready to take clinical and preclinical sample analysis to the next level. MasterKey will undoubtedly have a profound effect on accelerating the development of new life-saving treatments and maximising the knowledge gained from precious clinical trial samples. Congrats to the entire Inoviv team, looking forward to seeing the impact of this amazing work. https://lnkd.in/da9dQuTx
Inoviv Launches MasterKey™, A Customizable Platform for Multiplexed Targeted Protein Assays, Leveraging a Pre-Characterized Database of Thousands of Proteins
prnewswire.com
-
Inoviv reposted this
Today marks a significant milestone for Inoviv as we launch MasterKey! Seeing our team's dedication and hard work come to fruition has been very rewarding. MasterKey allows researchers to customize multiplex protein assays, providing precision and reliability like never before. This platform is a testament to our commitment to transforming drug development and healthcare. I’m proud of what we’ve achieved together and excited for the breakthroughs this tool will enable. A heartfelt thank you to everyone who contributed to this milestone! https://lnkd.in/gsp388M8
Inoviv Launches MasterKey™, A Customizable Platform for Multiplexed Targeted Protein Assays, Leveraging a Pre-Characterized Database of Thousands of Proteins
prnewswire.com
-
Inoviv reposted this
Proud to announce the launch of MasterKey, a tool that empowers researchers to create custom multiplexed protein assays with ease. This launch is a testament to our team’s innovation and dedication, and I am honoured to have been part of the journey. The platform’s ability to leverage our extensive protein database will enable significant advancements in research. MasterKey will provide precise and reliable data for therapeutic and clinical applications. I am excited for the future breakthroughs this tool will facilitate.
Inoviv Launches MasterKey™, A Customizable Platform for Multiplexed Targeted Protein Assays, Leveraging a Pre-Characterized Database of Thousands of Proteins
prnewswire.com